Showing 11 of 11 results

Sunil Bahl et al.
This analysis describes an innovative and successful approach to risk identification and mitigation in relation to the switch from trivalent to bivalent oral polio vaccine (OPV) in the 11 countries...
Simona Zipursky et al.
The Immunization Systems Management Group (IMG) was established to coordinate and oversee objective 2 of the Polio Eradication and Endgame Strategic Plan 2013–2018, namely, (1) introduction of ≥1...
Abhishek Kunwar, Sunil Bahl, Mohammad Ahmad
Evidence generated through research studies has guided programmatic actions and fine-tuned strategies for the Global Polio Eradication Initiative (GPEI). However, many gaps still persist in the...
Haldar P & Agrawal P
Global Polio Eradication and Endgame Strategic Plan 2013-18 calls for the ultimate withdrawal of oral polio vaccines (OPV) from all immunization programs across the world. The phased globally...
Julie Garon et al.
As the polio endgame progresses, the world will increasingly rely on inactivated polio vaccine (IPV) for protection against polio (wild and vaccine-related) and for risk mitigation during the phased...
Sunil Bahl et al.
Wild poliovirus type 2 was declared eradicated in September 2015. As part of a globally-synchronized effort to withdraw Sabin poliovirus type 2 vaccine, India switched from use of trivalent oral...
Jacob John et al.
Intestinal immunity induced by oral poliovirus vaccine (OPV) is imperfect and wanes with time, permitting transmission of infection by immunised children. Inactivated poliovirus vaccine (IPV) does...
Concepción F Estívariz
The continued presence of polio in northern India poses challenges to the interruption of wild poliovirus transmission and the management of poliovirus risks in the post-eradication era. We aimed to...
Roland W Sutter et al.
Polio eradication needs a new routine immunisation schedule—three or four doses of bivalent type 1 and type 3 oral poliovirus vaccine (bOPV) and one dose of inactivated poliovirus vaccine (IPV),...
Wanfei Yang et al.
Open vial vaccine wastage in multi-dose vials is a major contributor to vaccine wastage. Although switching from 10-dose vials to 5-dose vials could reduce wastage, a higher total cost could be...
World Health Organization (WHO)
This report, prepared by the Secretariat for the Decade of Vaccines Global Vaccine Action Plan, serves as the basis for the independent review. As was the case in 2013 and 2014, this report reviews...